Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Medecine Sciences : M/S
|
December 29, 2009
[Neonatal Fc receptor, key control of immunoglobulins biodistribution]
Charlotte Magdelaine-Beuzelin, Marc Ohresser, Hervé Watier
Lancet (London, England)
|
December 26, 2006
Risk in drug trials
Marc Ohresser, Daniel Olive, Bernard Vanhove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies
Julien Lejeune, Gilles Thibault, David Ternant, et al.
Blood
|
August 5, 2005
Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies
David Ternant, Marc Ohresser, Cécile Thomas, et al.
Bulletin Du Cancer
|
November 6, 2007
[Target antigens for therapeutic antibodies in oncology: many candidates, few successes]
Nicolas Ceze, Alicia Probst, Thierry Lecomte, et al.
Mabs
|
October 4, 2012
FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population
Julien Lejeune, Benoît Piègu, Valérie Gouilleux-Gruart, et al.
Cancer Research
|
February 19, 2008
Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype
Nicolas Congy-Jolivet, Armelle Bolzec, David Ternant, et al.
Critical Reviews in Oncology/Hematology
|
January 2, 2007
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment
Severine Loisel, Marc Ohresser, Marc Pallardy, et al.
Pharmacogenetics and Genomics
|
December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients
David Ternant, Matthias Büchler, Gilles Thibault, et al.
Clinical Colorectal Cancer
|
November 21, 2017
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?
Sajida Ibrahim, Alban Girault, Marc Ohresser, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Medecine Sciences : M/S
|
December 29, 2009
[Neonatal Fc receptor, key control of immunoglobulins biodistribution]
Charlotte Magdelaine-Beuzelin, Marc Ohresser, Hervé Watier
Lancet (London, England)
|
December 26, 2006
Risk in drug trials
Marc Ohresser, Daniel Olive, Bernard Vanhove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies
Julien Lejeune, Gilles Thibault, David Ternant, et al.
Blood
|
August 5, 2005
Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies
David Ternant, Marc Ohresser, Cécile Thomas, et al.
Bulletin Du Cancer
|
November 6, 2007
[Target antigens for therapeutic antibodies in oncology: many candidates, few successes]
Nicolas Ceze, Alicia Probst, Thierry Lecomte, et al.
Mabs
|
October 4, 2012
FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population
Julien Lejeune, Benoît Piègu, Valérie Gouilleux-Gruart, et al.
Cancer Research
|
February 19, 2008
Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype
Nicolas Congy-Jolivet, Armelle Bolzec, David Ternant, et al.
Critical Reviews in Oncology/Hematology
|
January 2, 2007
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment
Severine Loisel, Marc Ohresser, Marc Pallardy, et al.
Pharmacogenetics and Genomics
|
December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients
David Ternant, Matthias Büchler, Gilles Thibault, et al.
Clinical Colorectal Cancer
|
November 21, 2017
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?
Sajida Ibrahim, Alban Girault, Marc Ohresser, et al.
Page
of 2